Fox NewsHealth
Weight-loss drug may ease sleep apnea disruptions
In trials involving people with obstructive sleep apnea, Eli Lilly’s experimental drug retatrutide reduced breathing interruptions and led to substantial weight loss. Researchers also reported cardiovascular benefits, suggesting the treatment may address several health risks linked to the condition.
This card is an AI-assisted summary of reporting published by Fox News. Read the original report before relying on it for medical, legal, financial, safety, or emergency decisions.